within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P02D_Anticestodals.P02DX01_Desaspidin;

model Desaspidin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.5,
    Cl = 8.333333333333333e-07,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0008333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Desaspidin</td></tr><tr><td>ATC code:</td><td>P02DX01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>50</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Desaspidin is a phenolic compound derived from ferns, historically used as an anthelmintic agent, particularly for the expulsion of tapeworms. It is not in clinical use today and is not approved by contemporary regulatory agencies due to efficacy and safety concerns.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic data available for desaspidin. Estimates provided below are based on typical oral anthelmintic agents and extrapolation from historical usage.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.P.P02DX01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Desaspidin;
